Stock Market & Financial Investment News

News Breaks February 8, 2013 07:13 EDT THOR Thoratec downgraded to Market Perform from Outperform at Northland Securities Northland downgraded Thoratec following the CMS's announcement to initiate a National Coverage Decision analysis for VAD therapy. The firm believes there is now significant uncertainty regarding VADs and margins. Price target is $35. News For THOR From The Last 14 Days Check below for free stories on THOR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 12, 2013 10:14 EDT THOR On the Fly: Upgrade Summary Subscribe for More Information 06:53 EDT THOR Thoratec upgraded to Outperform from Market Perform at Raymond James Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.